Michelle Dipp, Co-Founder of Biospring Partners, discusses focusing investments on new ways of manufacturing from the creation of new drugs to innovations in synthetic biology and gene editing.
Hosts: Carol Massar and Tim Stenovec. Producer: Paul Brennan.

Inside the AI Revival of the Infamous Three Mile Island Nuclear Plant
44:32

The Intersection of Human Psychology with AI
08:21

C-Suite Conversations on Consumer Health, Earnings
25:52